# A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

> **NCT00703469** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 54 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** MDX1106-02
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00703469
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2010-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703469, "A Study of MDX-1106 to Treat Patients With Hepatitis C Infection". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00703469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*